Tissue plasminogen activator for the treatment of intraabdominal abscesses in a neonate

Journal of Pediatric Surgery

Volumn 38, Issue 8, 2003, Pages 1234-1236

  Diamond, Ivan R ^a   Wales, Paul W ^a   Connolly, Bairbre ^a   Gerstle, Ted ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Abscess; Fibrinolysis; Tissue plasminogen activator

Indexed keywords

AMPICILLIN; DOPAMINE; ENOXAPARIN; GENTAMICIN; KAOLIN PECTIN; METRONIDAZOLE; TISSUE PLASMINOGEN ACTIVATOR;

ABDOMINAL ABSCESS; ABDOMINAL DISTENSION; ABSCESS DRAINAGE; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FEMORAL VEIN; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; FOLLOW UP; HUMAN; INFANT; INTESTINE PERFORATION; LETHARGY; PERCUTANEOUS DRAINAGE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; TREATMENT FAILURE; VEIN THROMBOSIS;

EID: 0041358864     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(03)00275-6     Document Type: Article

References (15)

1. Kornecki A, Sivan Y: Treatment of loculated pleural effusion with intrapleural urokinase in children. J Pediatr Surg 32:1473-1475, 1997
2. Rotstein OD: Role of fibrin deposition in the pathogenesis of intraabdominal infection. Eur J Clin Microbiol Infect Dis 11:1064-1068, 1992
3. Ahrenholz DH, Simmons RL: Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery 88:41-46, 1980
4. Rotstein OD, Kao J: Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator. J Infect Dis 158:766-772, 1988
5. van Goor H, de Graaf S, Kooi K, et al: Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis. J Am Coll Surg 179:407-411, 1994
6. Mc Ritchie DI, Cummings D, Rotstein OD: Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation. Arch Surg 124:1406-1410, 1989
7. van Goor H, de Graaf S, Kooi K, et al: Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator. J Am Col Surg 181:38-42, 1995
8. Houston KA, Mc Ritchie DI, Rotstein OD: Tissue plasminogen activator reverses the deliterious effect of infection on colonic wound healing. Ann Surg 211:130-135, 1990
9. Lahorra JM, Haaga JR, Stellato T, et al: Safety of intracavitary urokinase with percutaneous abscess drainage. AJR 160:171-174, 1993
10. Kelly IMG, Boyd CS, Kennedy PT: Adjuvant urokinase therapy in percutaneous drainage of a multiloculated splenic abscess. J Vasc Interv Radiol 10:919-923, 1999
11. Haaga JR, Nakamoto D, Stellato T, et al: Intracavitary urokinase for enhancement of percutaneous abscess drainage: Phase II trial. AJR 174:1681-1685, 2000
12. Holden RW: Plasminogen activators: Pharmacology and therapy. Radiology 174:993-1001, 1990
13. Park JK, Kraus FC, Haaga JR: Fluid flow during percutaneous drainage procedures: An in vitro study of the effects of fluid viscosity, catheter size, and adjunctive urokinase. AJR 160:165-169, 1993
14. Duch JM, Yee J: Sucessful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis. Am J Kid Dis 37:149-153, 2001
15. Worland MA: Intraperitoneal thrombolytic therapy for peritoneal dialysis-associated peritonitis. Ann Pharmacother 32:1216-1220, 1998